Submitted by Anonymous (not verified) on 10 April 2025 - 14:20
Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised
Source: